(1)
Díaz, C.; Zapata, C. Profound Molecular Response With Ponatinib in Chronic Phase of Chronic Myeloid Leukemia With Resistance to Imatinib and Dasatinib: Case Report and Review of the Literature. Rev Méd Hered 2022, 33, 133-138.